Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cardiac MRI Software Designer Pettigrew Appointed First NIBIB Director

This article was originally published in The Gray Sheet

Executive Summary

Emory University Frederik Philips MR Research Center Director Roderic Pettigrew will bring extensive knowledge of three-dimensional heart imaging to his role as director of the National Institute of Biomedical Imaging & Bioengineering

You may also be interested in...



Image-Guided Intervention, Biomaterials Research Sought By NIBIB

Development of "real-time" treatment monitoring is one of several areas of 1image-guided interventions research that may be funded by the National Institute of Biomedical Imaging & Bioengineering in FY 2003

Image-Guided Intervention, Biomaterials Research Sought By NIBIB

Development of "real-time" treatment monitoring is one of several areas of 1image-guided interventions research that may be funded by the National Institute of Biomedical Imaging & Bioengineering in FY 2003

Radiologist Zerhouni Ready To Take Reins At NIH; Six More Chiefs In Waiting

Elias Zerhouni, MD, will target as one of his first priorities as National Institutes of Health director the recruitment of individuals to fill leadership spots at several NIH institutes and centers

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016526

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel